Polyphenol Oxidase as a Promising Alternative Therapeutic Agent for Cancer Therapy

Qinqin Yuan1, Huixia Guo1, Jiajie Ding1

  • 1College of Ecological Technology and Engineering, Shanghai Institute of Technology, Shanghai 201418, China.

Insights

Polyphenol oxidase (PPO) from edible mushrooms effectively inhibits cancer cell growth, migration, and invasion. This traditional Chinese medicine component also promotes cancer cell apoptosis, showing promise as a novel anticancer therapeutic agent.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Cancer remains a significant global health challenge, necessitating novel therapeutic strategies.
  • Traditional Chinese medicine offers a rich source of potential anticancer compounds.
  • Polyphenol oxidase (PPO) from edible mushrooms has known biochemical properties but its anticancer potential is largely unexplored.

Purpose of the Study:

  • To investigate the in vitro effects of edible mushroom-derived PPO on cancer cell proliferation, migration, invasion, and apoptosis.
  • To evaluate the in vivo therapeutic efficacy of PPO on tumor growth.

Main Methods:

  • In vitro assays included Cell Counting Kit-8 (CCK8) for proliferation, scratch test for migration, Transwell assay for invasion, and flow cytometry for apoptosis.
  • In vivo studies utilized female BALB/c mice with tumor models, comparing control, model, and low/high dose PPO treatment groups (25 mg/kg, 50 mg/kg).

Main Results:

  • PPO significantly inhibited proliferation, migration, and invasion of breast (4T1), lung (A549), and prostate (C4-2) cancer cells in vitro.
  • PPO significantly promoted apoptosis in 4T1, A549, and C4-2 cancer cells in vitro.
  • In vivo experiments demonstrated that PPO effectively inhibited tumor growth.

Conclusions:

  • Edible mushroom-derived PPO exhibits significant anticancer properties against various cancer cell lines in vitro.
  • PPO demonstrates therapeutic potential for inhibiting tumor growth in vivo.
  • PPO represents a promising novel agent for cancer treatment, warranting further investigation.

Related Concept Videos

Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
14.7K
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
413